Halozyme partners with Oruka for psoriasis drug development deal
Go back to Halozyme partners with Oruka for psoriasis drug development deal| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.17 +2.05 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.12 | 52 Week High | $18.39 | |||
| Open | $106.20 | 52 Week Low | $6.96 | |||
| Day High | $108.49 | P/E | N/A | |||
| Day Low | $105.91 | EPS | $-0.58 | |||
| Volume | 1,173,974 | |||||
| (NASDAQ: ORKA) | Delayed: 107.96 +3.10 (2.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.86 | 52 Week High | $ | |||
| Open | $105.48 | 52 Week Low | $ | |||
| Day High | $109.52 | P/E | N/A | |||
| Day Low | $103.86 | EPS | $ | |||
| Volume | 935,784 | |||||
